| Absorption |
| Blood-Brain Barrier | BBB+ | 0.8788 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.5478 |
| P-glycoprotein Substrate | Substrate | 0.7377 |
| P-glycoprotein Inhibitor | Inhibitor | 0.6425 |
| Inhibitor | 0.6884 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.5199 |
| Distribution |
| Subcellular localization | Mitochondria | 0.4039 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7888 |
| CYP450 2D6 Substrate | Substrate | 0.6144 |
| CYP450 3A4 Substrate | Substrate | 0.6870 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7517 |
| CYP450 2C9 Inhibitor | Inhibitor | 0.5698 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.5709 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.8086 |
| CYP450 3A4 Inhibitor | Inhibitor | 0.6380 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5815 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.5446 |
| Inhibitor | 0.7798 |
| AMES Toxicity | Non AMES toxic | 0.5670 |
| Carcinogens | Non-carcinogens | 0.7115 |
| Fish Toxicity | High FHMT | 0.9964 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8900 |
| Honey Bee Toxicity | Low HBT | 0.6161 |
| Biodegradation | Not ready biodegradable | 0.8889 |
| Acute Oral Toxicity | III | 0.5630 |
| Carcinogenicity (Three-class) | Non-required | 0.5876 |